Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term persistence of Hib-MenC booster vaccine (Menitorix)
NCT00322335Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Jul 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Hib-MenC-TT in Haemophilus influenzae type b infection (Hib), Serogroup C meningococcal disease (MenC), sponsored by GSK. Started May 2006; status: completed.
02
Drugs
Hib-MenC-TT
03
Conditions
Haemophilus influenzae type b infection (Hib)Serogroup C meningococcal disease (MenC)
Beyond the preview
Go deeper on NCT00322335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00322335.